Back to top
more

Ventas (VTR)

(Delayed Data from NYSE)

$48.70 USD

48.70
3,767,175

-0.01 (-0.02%)

Updated May 16, 2024 03:59 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.20%
2Buy18.04%
3Hold9.52%
4Sell5.20%
5Strong Sell2.60%
S&P50011.13%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

D Value C Growth C Momentum D VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 44% (139 out of 250)

Industry: REIT and Equity Trust - Other

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Zacks News

Ventas, Inc. is a healthcare real estate investment trust (REIT) that is primarily engaged in acquisition and ownership of senior housing, R&I and healthcare properties, and leasing them to unaffiliated tenants or operating them through independent third-party managers. Ventas offers MOB management, leasing, marketing, facility development and advisory services to well-rated hospitals and health systems throughout the United States through its ownership interest in PMB Real Estate Services LLC and the company’s subsidiary, Lillibridge Healthcare Services, Inc. It also makes secured and non-mortgage loans and other investments relating to senior housing and healthcare properties or operators.

Ahead of Ventas (VTR) Q4 Earnings: Get Ready With Wall Street Estimates for Key Metrics

by Zacks Equity Research

Get a deeper insight into the potential performance of Ventas (VTR) for the quarter ended December 2023 by going beyond Wall Street's top -and-bottom-line estimates and examining the estimates for some of its key metrics.

Nalak Das headshot

Top 5 Dividend-Paying Stocks Set to Beat on Earnings Next Week

by Nalak Das

We have narrowed our search to five dividend-paying large-cap stocks that are poised to beat on earnings next week. These are: WM, QSR, TAP, LDOS, VTR.

Will Solid Transaction Growth Aid Euronet's (EEFT) Q4 Earnings?

by Zacks Equity Research

Euronet's (EEFT) Q4 results are expected to reflect the benefits of an expanding POS acquiring business and growth in international money transfers. Inflationary headwinds are likely to have escalated costs.

Alexandria's (ARE) Q4 AFFO Misses Estimates, '24 View Issued

by Zacks Equity Research

Alexandria's (ARE) Q4 results reflect lower-than-anticipated AFFO per share despite a rise in revenues. It has also issued its 2024 outlook.

SL Green's (SLG) Q4 FFO Lag Estimates, 2024 View Raised

by Zacks Equity Research

SL Green's (SLG) Q4 FFO misses estimates on lower-than-anticipated revenues. However, same-store cash net operating income improves year over year.

Crown Castle's (CCI) Q4 AFFO Beat Estimate, Revenues Down Y/Y

by Zacks Equity Research

Crown Castle's (CCI) Q4 results outshine estimates on better-than-anticipated revenues. However, high interest expense is a concern. It has maintained its 2024 outlook.

Crown Castle's (CCI) Q4 AFFO Beat, Site-Rental Revenues Up

by Zacks Equity Research

Crown Castle's (CCI) Q4 earnings outshine estimates on elevated fiber segment revenues. Site-rental revenues grow year over year, aiding the top line.

Here's Why Investors Should Retain Ventas (VTR) Stock for Now

by Zacks Equity Research

A rise in healthcare spending by senior citizens and accretive investments in the research portfolio bode well for Ventas (VTR). However, dependence on a few tenants and high interest rates are woes.

Ventas' (VTR) Q3 FFO Beat on SHOP NOI Growth, '23 View Revised

by Zacks Equity Research

Ventas's (VTR) Q3 earnings outshine estimates on better-than-anticipated revenues. The same-store cash NOI rises year over year on strong performance across the portfolio. The company has revised its 2023 outlook.

Compared to Estimates, Ventas (VTR) Q3 Earnings: A Look at Key Metrics

by Zacks Equity Research

Although the revenue and EPS for Ventas (VTR) give a sense of how its business performed in the quarter ended September 2023, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

Is a Beat in the Offing for Ventas (VTR) in Q3 Earnings?

by Zacks Equity Research

Favorable senior housing operating portfolio operating trends, robust demand for life-science real-estate assets and accretive investments are likely to have benefited Ventas' (VTR) Q3 earnings.

Regency Centers (REG) to Post Q3 Earnings: What's in Store?

by Zacks Equity Research

Healthy demand for Regency Centers' (REG) shopping centers and gains from accretive acquisitions are likely to have benefited its Q3 earnings. However, higher interest rates might have ailed.

Factors to Impact Innovative Industrial's (IIPR) Q3 Earnings

by Zacks Equity Research

With the cannabis industry gaining prominence, Innovative Industrial's (IIPR) investments in such properties are likely to have aided its Q3 performance, though high expenses might have played a spoilsport.

Key Factors to Impact Boston Properties' (BXP) Q3 Earnings

by Zacks Equity Research

Healthy demand for Boston Properties' (BXP) premium office and life-science assets is likely to have benefited its Q3 earnings. However, higher interest expenses might have hurt it.

What's in the Offing for Host Hotels (HST) in Q3 Earnings?

by Zacks Equity Research

Host Hotels' (HST) Q3 earnings are likely to have benefited from the continued strength in group travel and business transient demand. However, higher interest expenses might have hurt it.

Is a Beat in the Cards for Welltower (WELL) in Q3 Earnings?

by Zacks Equity Research

Welltower's (WELL) Q3 earnings are likely to have benefited from the rise in senior citizen's healthcare expenditure and accretive capital deployment activity.

Is a Beat in Store for Healthpeak (PEAK) in Q3 Earnings?

by Zacks Equity Research

Robust demand for Healthpeak's (PEAK) lab assets and a rise in senior citizen's healthcare expenditure are expected to have benefited its Q3 earnings.

Getty Realty (GTY) Tops Q3 FFO and Revenue Estimates

by Zacks Equity Research

Getty Realty (GTY) delivered FFO and revenue surprises of 1.79% and 9.33%, respectively, for the quarter ended September 2023. Do the numbers hold clues to what lies ahead for the stock?

Here's Why Investors Should Retain Ventas (VTR) Stock for Now

by Zacks Equity Research

A rise in healthcare spending by senior citizens and accretive investments in the research portfolio bode well for Ventas (VTR). However, dependence on a few tenants and high interest rates are woes.

Ventas (VTR) Partners With Operators for Senior Housing Growth

by Zacks Equity Research

Ventas (VTR) teams up with expert operators to enhance the performance of 26 independent living communities.

Medical Properties (MPW) Beats on Q2 FFO, Narrows '23 View

by Zacks Equity Research

Medical Properties' (MPW) Q2 results reflect lower-than-anticipated revenues. Higher interest expenses during the quarter act as a dampener. The company narrows its 2023 outlook.

Digital Realty (DLR) Unveils Solution to Meet Data Challenges

by Zacks Equity Research

Digital Realty (DLR) unveils high-density colocation service across its global data center platform, PlatformDIGITAL, to help businesses address data and AI growth challenges, and optimize performance.

Four Corners (FCPT) Buys $1.6M Iowa Property, Bolsters Growth

by Zacks Equity Research

Four Corners (FCPT) bolsters its external growth strategy with its recent acquisition of a Jiffy Lube property in Iowa for $1.6 million.

Four Corners (FCPT) Boosts Portfolio With Strategic Buyouts

by Zacks Equity Research

To boost its portfolio with real estate leased to strong credit operators, Four Corners (FCPT) announces the acquisition of a dual-tenant Aspen Dental and WellNow Urgent Care property.

Ventas' (VTR) Q2 FFO Beats, SHOP NOI Up, '23 View Revised

by Zacks Equity Research

Ventas (VTR) posts solid Q2 results on better-than-anticipated revenues. The same-store cash NOI rises year over year on strong performance across the portfolio. The company revises its 2023 outlook.